Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Current Taxes: 2021

  • Mereo BioPharma Group's Current Taxes was N/A to $2.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Mereo BioPharma Group reported Current Taxes of $2.1 million as of Q4 2021.
  • Mereo BioPharma Group's 5-year Current Taxes high stood at $2.1 million for Q4 2021, and its period low was $2.1 million during Q4 2021.
  • Over the past 1 years, Mereo BioPharma Group's median Current Taxes value was $2.1 million (recorded in 2021), while the average stood at $2.1 million.